MedPharm, Ltd., a global topical and transdermal contract development and manufacturing organization (CDMO), has appointed Daniel Morland to the company’s senior leadership team as senior director of sales and marketing. This announcement follows the recent appointment of Lynn Allen as CEO.

Morland joined MedPharm in 2018 as a senior business development manager. He has more than 15 years of experience in the pharmaceutical industry with an emphasis on contract services. He has worked in sales and management roles at organizations such as Reading Scientific Services, Butterworth Laboratories, and Simbec-Orion. He holds an MBA from the University of Warwick Business School.

Morland will be based out of MedPharm’s headquarters in Guildford, Surrey, and will lead the CDMO’s global commercial efforts.

“We are excited to welcome Dan back to MedPharm,” said CEO Lynn Allen. “His deep knowledge of MedPharm’s services and breadth of experience will be key to MedPharm’s continued growth.”